Aspira Women’s Health (AWH) announced the successful completion of the first development milestone of its Advanced Research Projects Agency for Health, ARPA-H, award. As a result, Aspira has received a $2M cash payment under the terms of the related agreement. As previously announced, Aspira will receive $10 million in funding over two years through the Sprint for Women’s Health launchpad track for later-stage health solutions. The first milestone encompassed the initial launch activities including the development of project execution and risk mitigation plans, and activities related to the expansion of Aspira’s subject matter and laboratory capabilities. Deliverables provided to ARPA-H to support the achievement of the milestone included detailed project plans, process and governance models, expansion plans for the research and commercial molecular lab, and product opportunity and technical feasibility reports.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AWH:
- Aspira Women’s Health Reports Q3 2024 Growth and Strategic Advances
- Aspira Women’s Health reports Q3 revenue $2.3M, consensus $2.73M
- Aspira Women’s Health Inc. (AWH) Q3 Earnings Cheat Sheet
- Aspira Women’s Health expands collaboration with Bioreference
- Aspira Women’s Health Highlights Future Product Developments